Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

OSRHBearishLegalnews

High materiality8/10

OSR Health Faces Nasdaq Delisting; Major Volume Spurs Hearing Appeal

Aug 19, 2026, 3:47 PM EDT2 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Delisting risk and imminent trading suspension are material, likely triggering selling pressure and liquidity loss; historical delisting announcements often prompt declines as trading halts remove liquidity.

AI summary

What happened, with direct paths to the underlying reporting

OSR Health disclosed a Nasdaq delisting determination after failing to regain a $1 minimum bid. It will appeal via a Nasdaq Hearing Panel, citing extraordinary August activity (370M then 145M shares) with an 18.5M float as evidence of market interest. Trading will be suspended August 26 pending panel review, creating near-term volatility but potential continued listing if the panel approves.

Nasdaq delisting determination for OSRH over min bid price; appeals planned.
Aug 17-18 trading surge: 370M then 145M shares; 18.5M float; near $1.
OSR Health to request a Nasdaq hearing; CEO cites market conviction.
Trading suspension set for Aug 26; company will update shareholders.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.